Abstract: A power converter with secondary side regulation (SSR) for driving one or more output loads having capacitors (preferably Y-capacitors) for feedback and data transmission is disclosed. The power converter includes a transformer with primary and secondary windings, a primary circuit, a secondary circuit comprising a secondary controller, and a data transmission circuit comprising a plurality of capacitors. The primary circuit comprises one or more switching means and a primary controller. The secondary circuit is isolated from the primary circuit by the transformer and connected to the output loads and the secondary winding. The data transmission circuit connects the secondary circuit to the primary circuit for transmitting a feedback signal through to become a primary side feedback signal. The capacitors comprises one or more first capacitors on a feedback path and one or more second capacitors on a ground path.

Abstract: This disclosure relates to bivalent compounds (e.g., bi-functional small molecule compounds), compositions comprising one or more of the bivalent compounds, and to methods of use the bivalent compounds for the treatment of certain disease in a subject in need thereof. The disclosure also relates to methods for identifying such bivalent compounds.

Abstract: Technologies for a flexible three-dimensional power plane in a chassis are disclosed. In one embodiment, a flexible ribbon cable is laid along a circuit board tray. The flexible ribbon cable is secured to the tray using power bosses. The power bosses connect to one or more conductors on the ribbon cable. When the circuit board is mounted on the circuit board tray, the power bosses extend through holes in the circuit board and mate with power clips on the surface of the circuit board tray. The ribbon cable, power bosses, and power clips can distribute power to various locations on the circuit board, without requiring large traces that take up space on the circuit board.

Abstract: A combined sealing member for a coiled tubing blowout preventer box includes an upper plate, a first main sealing body, a second main sealing body and a lower plate that are disposed in sequence from top to bottom and are each provided with a through hole allowing a coiled tubing to pass therethrough. The upper plate is composed of two upper plate units that are separable half-and-half. The first main sealing body is composed of two first main sealing body units that are separable half-and-half. The second main sealing body is composed of two second main sealing body units that are separable half-and-half. The lower plate is composed of two lower plate units that are separable half-and-half. The first main sealing body has a hardness greater than that of the second main sealing body and a height smaller than that of the second main sealing body.

Abstract: Provided are bivalent compounds (e.g., bi-functional small molecule compounds), compositions comprising one or more of the bivalent compounds, and methods of use the bivalent compounds for the treatment of certain disease in a subject in need thereof, and methods for identifying such bivalent compounds.

Abstract: Medical devices and methods of using medical devices are disclosed. An example tissue retraction device includes a first engagement member having a first end and a second end, a second engagement member having a first end and a second end, a first elastic member attached to the second end of the first engagement member, and a first alignment member having a first end, a second end and a lumen extending therethrough. Further, the tissue retraction device has a first length, the first alignment member has a second length, the first elastic member extends within the lumen of the first alignment member and the second length of the first alignment member is less than or equal to the first length of the tissue retraction device.

Abstract: This application provides an electronic device, to reduce a probability that a screen stalling phenomenon. A timing control unit sends one first pulse of a tearing effect signal every a first preset time T1. The timing control unit sends S second pulses of the tearing effect signal when a transceiver unit does not receive an Nth frame of display data within a preset time. The processing unit receives the Nth frame of display data in the (N+1)th frame, and controls, based on the Nth frame of display data, the display to display an Nth frame of image.

Abstract: A method of forming a semiconductor memory device includes simultaneously filling a top portion of a first high aspect ratio (HAR) structure and a top portion a second HAR structure with a silicon-containing sacrificial layer by a cycle of a deposition process and an etch process, wherein the first HAR structure has a critical dimension (CD) of between 150 nm and 250 nm, and the second HAR structure has a CD of between 250 nm and 400 nm.

Abstract: Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.

Abstract: Techniques for detecting certain acoustic events from audio data are described. A system may perform event aggregation for certain types of events before sending an output to a device representing the event is detected. The system may bypass the event aggregation process for certain types of events that the system may detect with a high level of confidence. In such cases, the system may send an output to the device when the event is detected. The system may be used to detect acoustic events representing presence of a person or other harmful circumstances (such as, fire, smoke, etc.) in a home, an office, a store, or other types of indoor settings.

Abstract: This disclosure relates to heterobifunctional compounds (e.g., bi-functional small molecule compounds), compositions comprising one or more of the heterobifunctional compounds, and to methods of use the heterobifunctional compounds for the treatment of certain disease in a subject in need thereof. The disclosure also relates to methods for identifying such heterobifunctional compounds.

Abstract: This disclosure relates to GSPT1 degrader compounds (e.g. small molecule compounds), compositions comprising one or more of the compounds, and to methods of use the compounds for the treatment of certain disease in a subject in need thereof. The disclosure also relates to methods for identifying such compounds.

Abstract: Medical devices and methods of using medical devices are disclosed. An example tissue retraction device includes a first engagement member having a first end and a second end, a second engagement member having a first end and a second end, a first elastic member attached to the second end of the first engagement member, and a first alignment member having a first end, a second end and a lumen extending therethrough. Further, the tissue retraction device has a first length, the first alignment member has a second length, the first elastic member extends within the lumen of the first alignment member and the second length of the first alignment member is less than or equal to the first length of the tissue retraction device.

Abstract: A casting and outputting system is provided. The system includes a casting machine, a disc body, a transfer device, a special fixture, a cooling tank, a collection device and a waste plate rack. The transfer device is configured to drive the special fixture to take out anode plates cast on the disc body, place a qualified one of the anode plates in the cooling tank, place an unqualified one of the anode plates on the waste plate rack, lift the anode plate cooled in the cooling tank, and place the cooled anode plate on the collection device for stacking.

Abstract: A method of processing a substrate is provided including flowing a deposition gas comprising a hydrocarbon compound and a dopant compound into a process volume having a substrate disposed positioned on a substrate support. The process volume is maintained at a pressure of about 0.5 mTorr to about 10 mTorr. The method includes generating a plasma at the substrate by applying a first RF bias to the substrate support to deposit a doped diamond-like carbon film on the substrate. The doped diamond-like carbon film includes about 5 at. % to about 25 at. % of dopant and a first stress property. The method includes annealing the doped diamond-like carbon film at about 220° C. to about 450° C. to form an annealed film. The annealed film includes a second stress property. The second stress property having an absolute value less than or within 10% the first stress property.

Abstract: A hydrogen fuel cell forklift truck with a distributed architecture includes a frame, and, a hydrogen storage system, a fuel cell, a cooling system and an energy storage system arranged on the frame, and the fuel cell is connected with the hydrogen storage system and the energy storage system for charging the energy storage system and providing kinetic energy; the hydrogen storage system is located outside the fuel cell and exposed to the frame for supplying hydrogen to the fuel cell; the cooling system is located outside the fuel cell and connected to the fuel cell for cooling the fuel cell; the energy storage system is located outside the fuel cell and connected to the fuel cell for recovering braking energy and providing kinetic energy together with the fuel cell.

Abstract: This disclosure relates to bivalent compounds (e.g., bi-functional small molecule compounds), compositions comprising one or more of the bivalent compounds, and to methods of use the bivalent compounds for the treatment of certain disease in a subject in need thereof. The disclosure also relates to methods for identifying such bivalent compounds.

Abstract: The disclosure is directed to, in part, to BCL-2 inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.

Abstract: This disclosure relates to heterobifunctional compounds (e.g., bi-functional small molecule compounds), compositions comprising one or more of the heterobifunctional compounds, and to methods of use the heterobifunctional compounds for the treatment of certain disease in a subject in need thereof. The disclosure also relates to methods for identifying such heterobifunctional compounds.

Abstract: The present disclosure relates to the field of tissue dissection. Specifically, the present disclosure relates to medical devices that lift and retract tissue during a dissection procedure to improve visualization of the target tissue and mitigate obstructions for dissection tools. In particular, the present disclosure relates to devices that transition from a constrained to an unconstrained bowed configuration to immobilize and retract the dissected portion of target tissue during a dissection procedure.